These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1292 related items for PubMed ID: 8649798

  • 1. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
    Wang Y, Becker D.
    Oncogene; 1996 Mar 07; 12(5):1069-75. PubMed ID: 8649798
    [Abstract] [Full Text] [Related]

  • 2. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
    Reed JA, Loganzo F, Shea CR, Walker GJ, Flores JF, Glendening JM, Bogdany JK, Shiel MJ, Haluska FG, Fountain JW.
    Cancer Res; 1995 Jul 01; 55(13):2713-8. PubMed ID: 7796391
    [Abstract] [Full Text] [Related]

  • 3. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
    Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR, Fisher PB.
    Oncogene; 1995 May 04; 10(9):1855-64. PubMed ID: 7753561
    [Abstract] [Full Text] [Related]

  • 4. Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells.
    Zhang H, Rosdahl I.
    Int J Oncol; 2004 Feb 04; 24(2):331-5. PubMed ID: 14719109
    [Abstract] [Full Text] [Related]

  • 5. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J.
    Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J, Kratzke RA, Niehans GA, Lincoln CE.
    Cancer Res; 1995 Dec 15; 55(24):6006-11. PubMed ID: 8521382
    [Abstract] [Full Text] [Related]

  • 7. [Cyclin-dependent kinase inhibitory proteins in normal and transformed choroidal melanocytes].
    Mouriaux F, Maurage CA, Labalette P, Casagrande F, Malecaze F, Darbon JM.
    J Fr Ophtalmol; 1999 Apr 15; 22(3):339-46. PubMed ID: 10337591
    [Abstract] [Full Text] [Related]

  • 8. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 15; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 9. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
    Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N.
    Cancer Res; 2001 Sep 01; 61(17):6335-9. PubMed ID: 11522621
    [Abstract] [Full Text] [Related]

  • 10. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L, Goodrow TL, Zhang SY, Klein-Szanto AJ, Chang H, Ruggeri BA.
    Cancer Res; 1996 Mar 01; 56(5):1137-41. PubMed ID: 8640773
    [Abstract] [Full Text] [Related]

  • 11. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.
    Glendening JM, Flores JF, Walker GJ, Stone S, Albino AP, Fountain JW.
    Cancer Res; 1995 Dec 01; 55(23):5531-5. PubMed ID: 7585628
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
    Flørenes VA, Lu C, Bhattacharya N, Rak J, Sheehan C, Slingerland JM, Kerbel RS.
    Oncogene; 1999 Jan 28; 18(4):1023-32. PubMed ID: 10023678
    [Abstract] [Full Text] [Related]

  • 13. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O.
    IUBMB Life; 2004 Sep 28; 56(9):557-64. PubMed ID: 15590562
    [Abstract] [Full Text] [Related]

  • 14. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ, Li W, Sanki A, Colman MH, Yang YH, Thompson JF, Scolyer RA.
    Int J Surg Pathol; 2009 Oct 28; 17(5):361-7. PubMed ID: 19666944
    [Abstract] [Full Text] [Related]

  • 15. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 16. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr 15; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
    Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM, Reznikoff CA.
    Cancer Res; 1999 Jun 15; 59(12):2957-64. PubMed ID: 10383161
    [Abstract] [Full Text] [Related]

  • 19. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):1190-7. PubMed ID: 10741751
    [Abstract] [Full Text] [Related]

  • 20. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M, Xiong Y.
    Oncogene; 1996 Nov 07; 13(9):2033-8. PubMed ID: 8934552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.